The debate over banning or legalizing marijuana has been going on for higher than a century now, however it continues to be a brand new issue on the table. You can find individuals who strongly support its legalization, while there are many who vehemently oppose it. However, throughout the last decade, the debate has been tilted in support of cannabis as the term “medical marijuana” has gained momentum with assistance from legalization campaigns. Still, you will find others who are preventing it from going it all legal.
The findings of a recently available study also go in support of optimum medical utilization of marijuana. It says that the certain chemical present in marijuana can in fact help in treating patients with drug-resistant types of epilepsy. This new study has provided evidence that marijuana can succeed in treatment for one-third of epilepsy patients who’ve a treatment-resistant type of the disease.
The study titled “Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial” – published in The Lancet Neurology – says that almost one-third of epilepsy patients are treatment-resistant and are associated with severe morbidity and increased mortality. Though marijuana-based treatments for epilepsy have spiked the interest of individuals, scientific data on the subject is limited, feel the authors.
“We aimed to ascertain whether addition of cannabidiol to existing anti-epileptic regimens could be safe, tolerated, and efficacious in children and adults with treatment-resistant epilepsy,” the researchers said.
The researchers, led by Orrin Devinsky, neurologist at New York University Langone Medical Center, administered an extract of 99 percent cannabidiol (CBD) – a non-psychoactive chemical in marijuana – to 162 patients and monitored them for about 12 weeks. How does 500mg CBD Gummies compare against 1000mg and 250mg CBD gummy bears? The chemical was given as a supplement or add-on along with other preexisting medicines of the patients and was conducted on an open level, which means individuals were conscious of what they were given. The researchers observed that this intervention managed to cut back to motor seizures at a similar rate by the present drugs, but 2 percent of patients became completely seizure free.
Despite some very good results being shown by this technique, the researchers feel that there is need for further extensive studies on the subject. “Our findings suggest that cannabidiol might reduce seizure frequency and might have a sufficient safety profile in children and adults with highly treatment-resistant epilepsy. Randomized controlled trials are warranted to characterize the safety profile and true efficacy of this compound,” the analysis said.
This is not the very first time when this kind of observation has been made. Some previous studies had also drawn similar conclusions. A 2007 study, titled “Marijuana: An Effective Antiepileptic Treatment in Partial Epilepsy? A Case Report and Review of the Literature,” published in the Reviews in Neurological Diseases had also said that “marijuana or its active constituents could have a place in the treating partial epilepsy.”
Katherine Mortati, M.D., a neurologist at the Comprehensive Epilepsy Center at SUNY Downstate Medical Center, who’d conducted the analysis, said “In the analysis we present the case of a 45-year-old man with cerebral palsy and epilepsy who showed marked improvement with the utilization of marijuana. This case supports other anecdotal data suggesting that marijuana use might be a beneficial adjunctive treatment in some patients with epilepsy.”
Even The British Epilepsy Association had said in 2006 that “there’s scientific evidence to suggest that cannabis may be beneficial in treating several conditions, including epilepsy.”
More studies need to be done to locate proof of marijuana’s utility in working with epilepsy. Even if proved, marijuana will continue being an addictive substance, which can have several unwanted effects, like hallucinations, cravings and drug seeking behavior.